Francois-Clement Bidard, MD, PhD of Institut Curie
discusses Circulating tumor cells enumeration and Health Related Quality of Life of patients treated with first-line chemotherapy for HER2 negative metastatic breast cancer
COMET Trial: HER2- MBC with Slides Francois-Clement Bidard SABCS 22
By Editor